Sign in

CIK 0001000694

  • Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222816046
Phone
+1 240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Exercise or conversion +2,063 $5.95 $12K 3,170
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −109 $219.55 $24K 3,061
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −168 $220.33 $37K 2,893
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −250 $221.32 $55K 2,643
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −227 $222.39 $50K 2,416
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −188 $223.48 $42K 2,228
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −120 $224.93 $27K 2,108
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −248 $225.45 $56K 1,860
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −538 $226.59 $122K 1,322
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −569 $227.82 $130K 753
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −369 $228.64 $84K 384
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −38 $230.04 $9K 346
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −59 $231.40 $14K 287
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Sale −12 $232.35 $3K 275
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Exercise or conversion · Stock Option (Right to Buy) −416 4,176
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Exercise or conversion · Stock Option (Right to Buy) −416 9,175
2021-02-26 Herrmann John A III EVP, Chief Legal Officer Exercise or conversion · Stock Option (Right to Buy) −2,063 63,938
2021-02-18 Glenn Gregory M President, R&D Sale −80 $264.09 $21K 5,165
2021-02-18 Glenn Gregory M President, R&D Sale −361 $265.52 $96K 4,804
2021-02-18 Glenn Gregory M President, R&D Sale −128 $266.68 $34K 4,676

Page 68 of 87 · 1,734 trades